Click to search for your profile
Click to search for condition or expert
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Clinical Trials for
Dowling-Meara Epidermolysis Bullosa Simplex
Overview
Find a Doctor
Latest Advances
Clinical Trials
Active Clinical Trials
Search for trials
Clinical Trial
Status:
Recruiting
Intervention Type:
Other
Participants:
100
Start Date:
March 2, 2020
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
Clinical Trial
Status:
Recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
25
Start Date:
June 14, 2018
Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
Search for trials
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 2
Intervention Type:
Biological
Participants:
4
Start Date:
May 7, 2018
A Phase II Study of Beremagene Geperpavec (KB103), a Non-Integrating, Replication-Incompetent Herpes Simplex Virus 1 (HSV-1) Vector Expressing the Human Collagen VII (COL7) Protein, for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
Clinical Trial
Status:
Active, not recruiting
Intervention Type:
Procedure
Participants:
40
Start Date:
November 28, 2017
Computational Drug Repurposing for All Epidermolysis Bullosa Simplex (EBS) Cases
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
8
Start Date:
May 2016
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
Showing 1-5 of 5